When you buy prescription drugs, your doctor can ask you about your vision.
The law requires that prescription drug labels and prescription numbers be provided, but in many states, they’re not.
I need to have a prescription for my medicine, says a blind man with a medical condition.
He’s been living with his condition since he was 17, and has been getting the prescription filled from his pharmacist for the past 20 years.
He wants the law to change.
The problem, he says, is that it’s hard to get the paperwork that would require someone with a vision impairment to fill out an affidavit if they’re blind.
“There are a lot of places that you don’t have a legal prescription for,” he says.
For me, I’ve been trying to get it, he adds.
“But it’s very difficult.”
For more than a decade, the Drug Enforcement Administration has been looking into a way to make sure that Americans who can’t legally get their prescriptions filled can get them filled.
That’s why the DEA is working on a new rule that would allow Americans with vision impairments to fill prescriptions for any prescription drug, regardless of how much of an impairment the patient has.
But it hasn’t been easy.
The DEA’s draft rule would also expand the definition of “blind person” to include a person who has a disability that makes it difficult for them to read or write and has not received any special educational support from the government.
The new rule is the result of a meeting held by DEA and Health and Human Services officials last week to discuss how to handle the millions of Americans who have been denied access to their medication because of a legal vision impairment.
The meeting focused on ways to allow Americans who are blind to fill their prescriptions without being told that they are unable to read the prescription, and on the new definition of the term “blind.”
In addition, the DEA proposed to revise its rule to ensure that people who cannot read the prescribed medication must be shown the prescription and given a chance to fill it.
The DEA also proposed to extend the time for which a prescription can be filled for people who are legally blind.
And the rule, if finalized, could expand the DEA’s authority to require people with vision impairment-related disabilities to provide proof of their eligibility to fill prescription drugs.
The new rule would only apply to people with a prescription that is filled through an approved doctor or pharmacist, the FDA said.
It would not apply to individuals who are under the age of 18 or to people who were unable to get their medication from their doctor because of their vision impairment, according to a statement from the FDA.
As part of its work to expand the use of prescription drugs to people whose disabilities make it difficult to read, the agency has expanded its definition of blindness, which it has defined as a condition that makes the person unable to recognize or communicate clearly.
In the past, the definition has been limited to people diagnosed with glaucoma or chronic obstructive pulmonary disease, which is often diagnosed in conjunction with vision loss.
But a draft rule that has been leaked to the media suggests that the definition could expand to include people with other conditions as well, including people with chronic kidney disease, Alzheimer’s disease and other diseases.
At least one other drugmaker, Merck, has expressed concern about the rule.
Merck has been a vocal opponent of the rule because it would allow prescription drug manufacturers to deny patients who have a vision impairing condition the ability to fill a prescription because of some sort of legal disability.
The drugmaker said that it would oppose any new rules that would prevent people with legal blindness from filling their prescriptions.